Red Drugs, Broken Hearts: Debunking Myths and Revealing Truths in Predicting and Preventing Anthracycline-Induced Cardiotoxicity

Monday, June 16, 2025, 2:00 PM - 3:00 PM, Marlo Thomas GEC Meeting Room 2 - IA1405

Webex

1. Describe the pathophysiology of acute and chronic anthracycline-induced cardiotoxicity.
2. Recommend appropriate prevention and treatment strategies for managing anthracycline-induced cardiotoxicity.
3. Recall the role of cardiac biomarkers and genetic variants in the early detection and predisposition to anthracycline-induced cardiotoxicity.

Webex - Click Here

Reminders for claiming CE:

The St. Jude Children’s Research Hospital Department of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

St. Jude Children’s Research Hospital designates this {Activity Format} for a maximum of 1.00 CPE hours (0.1 CEU per 1 CPE hour).

Pharmacy continuing education credit will be available to all participants who attend, text attendance, and complete a program assessment and evaluation. Credits will be uploaded and viewable on-line at www.napb.net within approximately two weeks following the date of the presentation.  Participants should contact the CPE staff if credit does not appear within 4 weeks of a program.

 

ACPE - Accreditation Council for Pharmacy Education (1.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.